The Global Next Generation Sequencing Market was valued at USD xx million in 2017 and is estimated to reach USD xx million by 2025, with a CAGR of xx% during the forecast period (2019-2026).
What is Next Generation Sequencing?
Next-generation sequencing (NGS) refers to DNA sequencing technologies such as Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: Proton / PGM sequencing, SOLiD sequencing that allows sequencing DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing.
Whats trending in this market?
The market is driven by several factors such as increasing demand for NGS technology in drug discovery, growth in genome mapping programs and technological advancements in genetic sequencing.
The market is affected by standardization concerns over NGS based diagnostics and lack of skilled professionals in this field.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
